首页--医药、卫生论文--肿瘤学论文--神经系肿瘤论文

神经母细胞瘤疾病治疗的制度、政策之分析--以中国为例

ABSTRACT第4页
1 INTRODUCTION第8-28页
    1.1 Study Backgound第8-11页
    1.2 Significance of the Study第11-15页
    1.3 Argument and objectives第15-16页
    1.4 Review of Scholar Studies第16-23页
    1.5 Framework第23-26页
    1.6 Analysis of the Comprehensive Data Survey第26-28页
        1.6.1 Origin of the respondents第26-27页
        1.6.2 Possibility of treatment close to China第27-28页
2 NEUROBLASTOMA第28-30页
3 ECONOMIC ASPECTS第30-42页
    3.1 Coverage of the treatment in China by the healthcare system第30-32页
        3.1.1 Commercial insurances第31-32页
    3.2 Different types of public insurances and private platforms第32-33页
    3.3 Expense on NB treatment related to income第33-36页
    3.4 Availability of treatment in China第36-41页
    3.5 (Un)availability of treatment abroad provided by the public healthcare system第41-42页
4 CLINICAL ASPECTS第42-52页
    4.1 Reliance on the treatment第42-45页
        4.1.1 Second opinion第42-43页
        4.1.2 Alternative treatments第43-44页
        4.1.3 Confidence in the professionals and drugs第44-45页
    4.2 Diagnostic speed第45-46页
    4.3 Procedures第46-48页
    4.4 Availability of the doctors第48-52页
5 ASSISTANCE ASPECTS第52-63页
    5.1 Sources of information第52-54页
        5.1.1 Access to information to ask for a second opinion第54页
    5.2 Hospitalization services第54-57页
    5.3 Privacy第57-59页
    5.4 Prevention第59-60页
    5.5 Psychological support第60-61页
    5.6 Pain management第61-63页
6 OVERALL SATISFACTION AND IMPROVEMENT PROPOSALS MADE BY THEUSERS第63-66页
7 CONCLUSIONS第66-71页
Bibliography第71-74页
Appendix 1: Questionnaire第74-83页
Appendix 2: Interviews第83-122页
    Beijing family第83-93页
    Yunnan, Kunming family第93-103页
    Shandong, Zibo family第103-111页
    Shanghai family第111-122页
Appendix 3: Consent sheet第122-124页

论文共124页,点击 下载论文
上一篇:甘草查尔酮B对人乳腺癌MCF-7细胞周期阻滞及诱导凋亡作用的研究
下一篇:系统性淋巴结清扫对上皮性卵巢癌预后的META分析